The Independent Risk of Obesity and Diabetes and Their Interaction in COVID-19: A Retrospective Cohort Study.

TitleThe Independent Risk of Obesity and Diabetes and Their Interaction in COVID-19: A Retrospective Cohort Study.
Publication TypeJournal Article
Year of Publication2021
AuthorsTchang BG, Askin G, Sahagun A, Hwang J, Huang H, Curanaj FAMendelso, Seley JJ, Safford MM, Alonso LC, Aronne LJ, Shukla AP
JournalObesity (Silver Spring)
Volume29
Issue6
Pagination971-975
Date Published2021 06
ISSN1930-739X
KeywordsAged, Cohort Studies, COVID-19, Diabetes Mellitus, Female, Humans, Male, Middle Aged, Obesity, Retrospective Studies, Risk Factors, SARS-CoV-2
Abstract

OBJECTIVE: This study aimed to assess whether diabetes mellitus (DM) or obesity is an independent risk factor for severe coronavirus disease 2019 (COVID-19) outcomes and to explore whether the risk conferred by one condition is modified by the other.

METHODS: This retrospective cohort study of inpatient adults with COVID-19 used multivariable Cox regression to determine the independent effects of DM and obesity on the composite outcome of intubation, intensive care unit admission, or in-hospital mortality. Effect modification between DM and obesity was assessed with a statistical interaction term and an exploration of stratum-specific effects.

RESULTS: Out of 3,533 patients, a total of 1,134 (32%) had DM, 1,256 (36%) had obesity, and 430 (12%) had both. DM and obesity were independently associated with the composite outcome (hazard ratio [HR] 1.14 [95% CI: 1.01-1.30] and HR 1.22 [95% CI: 1.05-1.43], respectively). A statistical trend for potential interaction between DM and obesity was observed (P = 0.20). Stratified analyses showed potential increased risk with obesity compared with normal weight among patients with DM (HR 1.34 [95% CI: 1.04-1.74]) and patients without DM (HR 1.18 [95% CI: 0.96-1.43]).

CONCLUSIONS: DM and obesity are independent risk factors associated with COVID-19 severity. Stratified analyses suggest that obesity may confer greater risk to patients with DM compared with patients without DM, and this relationship requires further exploration.

DOI10.1002/oby.23172
Alternate JournalObesity (Silver Spring)
PubMed ID33694267
PubMed Central IDPMC8206993
Grant List / / Weill Cornell Friend Center Weight Fund /
1-UL1-TR002384-01 / / Clinical and Translational Science Center at Weill Cornell Medical College /
P30 DK111022 / DK / NIDDK NIH HHS / United States
P30 DK020541 / DK / NIDDK NIH HHS / United States
UL1 TR002384 / TR / NCATS NIH HHS / United States
P60 DK020541 / DK / NIDDK NIH HHS / United States

Weill Cornell Medicine Friedman Center for Nutrition & Inflammation 413 E. 69th Street, Seventh Floor New York, NY 10021